"We Envision Growth Strategies Most Suited
to Your Business"

U.S. Hearing Aids Market to Record CAGR of 11.3% Over 2025-2032; Surge in Elderly Population in U.S. to Spur Market Growth

March 28, 2025 | Healthcare

The U.S. hearing aids market size was valued at USD 4.94 billion in 2024 and is predicted to reach USD 5.47 billion in 2025. The market is anticipated to touch USD 11.54 billion by 2032, recording a CAGR of 11.3% over 2025-2032.

Fortune Business Insights™ presents this information in its latest report titled U.S. Hearing Aids Market Size, Share & Industry Analysis, By Product (Hearing Devices {BTE, ITE, RIC, CIC, and Others} and Hearing Implants {Cochlear Implants, and Bone Anchored Implants}), By Patient Type (Adult and Pediatric), By Severity (Mild, Moderate and Severe & Profound), By Distribution Channel (Government Services, Manufacturer Owned Retail Networks, National Retailers, Independent Retailers/Small Chains, and Online Retailers), and Country Forecast, 2025-2032”.

Hearing aid devices are sophisticated electronic instruments engineered to amplify sound and improve auditory perception for individuals experiencing hearing loss. They are designed to be worn either behind or within the ear canal. Cutting-edge innovations in hearing loss solutions and supportive government regulations are the main factors fueling the market's growth.

The COVID-19 pandemic disrupted the market, with reduced patient and procedure cancellations causing significant revenue declines for key hearing device players. Post-lockdown recovery in 2021 witnessed increased ENT clinic visits, procedures, and hearing device demand, driven by growing hearing loss prevalence and market approvals.

Apple Introduced Groundbreaking Hearing Health Features for AirPods Pro 2

In September 2024, Apple introduced groundbreaking sleep and hearing health features for AirPods Pro 2, offering an innovative OTC hearing aid solution tailored for individuals experiencing mild to moderate hearing impairment. These transformative capabilities extend cross-product lines, presenting a sophisticated approach to supporting users' health experiences that significantly impact global populations.

Surge in Elderly Population in U.S. to Spur Market Growth

Hearing aid devices are widely utilized to address hearing impairments in both adults and children. As the number of people experiencing audiological disorders continues to rise, the market for hearing aids is expected to grow significantly in the coming future. Furthermore, the surge in the elderly population in the U.S., which is particularly vulnerable to hearing loss, will likely drive further growth of the hearing aids market in the country. According to the United Nations, the number of people aged 65 and older in the U.S. is projected to rise from 35 million in 2000 to 80 million by 2040. This demographic shift is expected to generate substantial demand for hearing aids during the forecast period.

However, insufficient insurance reimbursement significantly impedes the widespread adoption of these devices among the population and restraints the U.S. hearing aids market growth.

Sonova and Demant A/S to Dominate the U.S. Market with Extensive Range of Technologically Sophisticated Devices

The hearing aids market is characterized by key industry players who have established significant market presence. Sonova has emerged as the market leader, offering an extensive range of technologically sophisticated devices for hearing impairments. Another company, Demant A/S, follows closely, demonstrating the second-largest revenue share through its comprehensive product portfolio and strategic positioning in the country.

Notable Industry Development:

  • May 2024: Sonova announced that it received FDA clearance for a self-replacement option for Phonak Lyric hearing devices. This new feature will allow certified Lyric providers in the U.S. to enable experienced users to replace their Lyric devices on their own, thereby improving accessibility and decreasing the need for in-office visits. 

List of the Companies Profiled in the Report

  • Sonova (Switzerland)
  • Demant A/S (Denmark)
  • GN Store Nord A/S (Denmark)
  • Cochlear Ltd (Australia)
  • WS Audiology (Denmark)
  • RION Co., Ltd. (Japan)
  • Starkey (U.S.)
  • MED-EL (Medical Electronics) (Austria)

To get a detailed report summary and research scope of this market, click here:

https://www.fortunebusinessinsights.com/u-s-hearing-aids-market-105653

Further Report Findings

  • Based on product, the hearing devices segment represented the largest portion of the U.S. hearing aids market in 2024. The expansion of this segment is supported by the increasing emphasis from hearing device manufacturers and audiology clinics on raising awareness about the advantages of these devices.
  • Based on patient type, the adult segment accounted for the maximum U.S. hearing aids market share in the coming years. The segment's growth can be attributed to the rising population numbers and the increasing incidence of hearing loss in adults.
  • Based on severity, the severe & profound segment comprised the major share of the market in 2024. Additionally, the increasing emphasis by companies on creating and launching innovative products for individuals with significant hearing loss is another key element driving the rising uptake in the market.

Table of Segmentation

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2024

Estimated Year

2025

Forecast Period

2025-2032

Historical Period

2019-2023

Unit

Value (USD Billion) and Volume (Units)

Growth Rate

CAGR of 11.3% from 2025-2032

Segmentation

By Product

  • Hearing Devices
    • BTE (Behind the Ear)
    • ITE (In the Ear)
    • RIC (Receiver in the Canal)
    • CIC (Completely in the Canal)
    • Others (Invisible in the Canal)
  • Hearing Implants
    • Cochlear Implants
    • Bone Anchored Implants

By Patient Type

  • Adult
  • Pediatric

By Severity

  • Mild
  • Moderate
  • Severe & Profound

By Distribution Channel

  • Government Services
  • Manufacturer Owned Retail Networks
  • National Retailers
  • Independent Retailers/Small Chains
  • Online Retailers

Healthcare
  • PDF
  • 2024
  • 2019 - 2023
  • 88

    CHOOSE LICENSE TYPE

  • 2850
    3850
    5250

Our Clients

 Kpmg
 LG Chem
 Mckinsey
 Mobil
 uniliver